Gabelli & Co Investment Advisers’s OptiNose OPTN Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-60,800	Closed	-$558K	–	276
2025 Q1	$558K	Buy	+60,800	New	+$382K	0.08%	132

Gabelli & Co Investment Advisers's OPTN Position: Q2 2025 in Review

Gabelli & Co Investment Advisers sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 60,800 shares — an estimated $558K sold.

Gabelli & Co Investment Advisers first reported a position in OPTN in Q1 2025 and held it in 1 quarter. The position peaked at $558K in Q1 2025. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.

Gabelli & Co Investment Advisers reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 60,800 OptiNose shares in Q2 2025, an estimated $558K.
Gabelli & Co Investment Advisers first reported a position in OptiNose in Q1 2025 and held it in 1 quarter.
Gabelli & Co Investment Advisers's OptiNose position peaked at $558K in Q1 2025.
0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.